Stock Spotlights Archives - Page 14 of 19

FridaySep 16, 2022 12:52 pm

TinyGemsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Rides on Horizontal, Vertical Growth to Log Best Revenue Quarter Ever

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, has weathered the geopolitical drama and international upheaval that fueled recession concerns amid spiking inflation. None of that stopped the company from having its best revenue quarter ever, spearheaded by horizontal and vertical growth. “The Las Vegas-based company logged record revenues exceeding $9 million in the quarter, an improvement of approximately 177% from $3.25 million in the comparable quarter of fiscal 2021,” a recent article reads. “Meaningful progress in both its flagship business-to-business (‘B2B’) and new business-to-consumer (‘B2C’) divisions undergirded the jump in revenue.…

ThursdaySep 15, 2022 1:35 pm

TinyGemsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Hypertension Treatment Program Stands Distinct

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently provided information to its stakeholders to help them conveniently research and understand different non-affiliated third-party sources and their methodologies for valuing biotech and pharmaceutical companies. The information includes a discussion of underlying logic-based evaluations that offer a realistic framework of expectations that investors can use in their analysis. “One of the logic-based evaluations considers the stage at which a company’s drug development program has reached. According to the U.S. Food and Drug Administration (‘FDA’), there are five steps to the drug development process: discovery and development, preclinical research, clinical research, FDA drug review, and,…

WednesdaySep 14, 2022 12:35 pm

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Marking Industry’s First-Ever Entry of Novel Psilocybin Analog into Clinical Development

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, is making significant headway with its flagship deuterated psilocybin analog, CYB003. “CYB003 has the potential to effectively treat alcohol use disorder (‘AUD’) and major depressive disorder (‘MDD’). The substance is designed to achieve less variability in plasma levels, faster onset of action, shorter duration of effect, and potentially better tolerability than oral psilocybin for a better patient outcome overall. Earlier this summer, Cybin received a ‘may proceed’ letter and Investigational New Drug Application (‘IND’) clearance from the U.S.…

MondaySep 12, 2022 10:00 am

TinyGemsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Acquisition of Controlling Stake in Bollinger Motors Featured in Recent Articles

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in recent articles published by InsideEVs and Newsweek that discussed its strategic move to purchase a controlling stake in Bollinger Motors. “EV fresh face Mullen Automotive has purchased a 60% controlling stake in Bollinger Motors for $148.2 million USD cash. It’s the company’s first EV acquisition after having purchased many of its building blocks from other enterprises along the way,” reads the Newsweek publication. The article quotes David Michery, CEO and chairman of Mullen Automotive, stating, “Combining Bollinger’s vehicles with our existing class 1 and class 2 EV…

ThursdaySep 08, 2022 1:39 pm

TinyGemsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) on Leading Edge of Psilocybin Research

Cybin (NYSE American: CYBN) (NEO: CYBN) is a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions. The company is on the leading edge of a transformation that has seen the status of psilocybin evolve as a result of mounting public acceptance and growing evidence that the substance delivers remarkable health benefits. “After a flurry of research in the 1950s and 1960s, psilocybin and all other psychedelics were abruptly banned, partly in response to their embrace by the counterculture. Following the 1971 United Nations Convention on Psychotropic Substances, psilocybin was classed in the U.S.…

TuesdayAug 30, 2022 1:38 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Positioned ‘Front and Center for Last-Mile Delivery Opportunities’

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, owns and partners with several synergistic businesses to create clean and scalable EVs and energy solutions. “The company’s ability to reach this goal can perhaps be measured by its success, which was recently on display when Mullen inked a deal with DelPack Logistics LLC (‘DPL’) for up to 600 Mullen Class 2 Electric Cargo Vans. The two companies entered a binding agreement calling for DPL, an Amazon delivery service partner, to purchase the EVs over the next 18 months; the first 300 will be ready for delivery by Nov. 30,…

MondayAug 29, 2022 1:43 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Taking MMT(R) Mainstream, Focusing Efforts on ‘Biggest Market for Lidar’

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, is taking Micro Motion Technology (“MMT(R)”) mainstream under the guidance of CEO and lidar pioneer Dr. Jun Pei. “Lidar uses lasers to generate 3D images and provides vital information including distance, speed and dimensions. This enables accurate detection tracking of objects based on real-time data. Emerging lidar applications include autonomous vehicles (‘AVs’), advanced driver assistance systems (‘ADAS’), traffic and pedestrian monitoring in smart cities, security and facility management, crowd analytics, and various industrial applications,” a recent article reads. “Cepton offers near-range to ultra-long-range lidar sensors, automotive software…

MondayAug 29, 2022 1:33 pm

TinyGemsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Streamlining NAFTA Region’s Cross-Border Shipping Process

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), through its Fr8App platform, offers a cloud-based marketplace that simplifies the once-complex process of international over-the-road (“OTR”) cross-border shipping. Innovative solutions offer quick and safe cross-border shipments while streamlining daily carrier operations. “The platform functions just as well for domestic, intra-country operations in each of the countries of the United States of America, Mexico or Canada. Because of this and other offerings in the Fr8Tech solutions suite, including but not limited to Fr8Radar, Fr8TMS and Fr8FMS, the company has come to be known for developing solutions to optimize and automate the supply chain process, offering…

FridayAug 26, 2022 2:00 pm

TinyGemsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) on Target to Own, Control ‘the Elements’ to Supply EV, Renewable Energy, Other Technology Manufacturers

Energy Fuels (NYSE American: UUUU) (TSX: EFR) recently entered into binding agreements to acquire 17 mineral concessions in Brazil. A recent article reads: “The acquisitions, located in the state of Bahia and total approximately 58 square miles, have the potential to provide UUUU’s White Mesa Mill with large quantities of rare-earth-element and uranium-bearing natural monazite sand for decades. “This is another very significant step in Energy Fuels’ development as a major global rare earth element producer based in the United States,” said Energy Fuels CEO and President Mark Chalmers. “We are aggressively seeking to expand our monazite sand feeds. With…

ThursdayAug 25, 2022 1:36 pm

TinyGemsBreaks – QSAM Biosciences Inc. (QSAM) Receives ‘Marketable Advantage’ Toward Manufacturing, Supply Chain of CycloSam(R)

QSAM Biosciences (OTCQB: QSAM) recently received a key patent for its exclusive radiopharmaceutical drug candidate, CycloSam(R), from the U.S. Patent & Trademark Office. “The patent protects how CycloSam is formulated and prepared, namely by using a nonradioactive kit that can be delivered and stored local to the administration site and provides for high purity in an efficient, facile and reproducible process at lower costs… The scope of this patent is fairly broad in that it not only protects the use of QSAM’s primary radioisotope, Samarium-153 (Sm-153), but also several other radioactive materials used in commercialized radiopharmaceuticals such as Lutetium-177 (Lu-177)…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: Stock Spotlights